Sphera Funds Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-177,094
Closed -$271K 118
2024
Q4
$271K Sell
177,094
-50,000
-22% -$81.3K 0.05% 104
2024
Q3
$411K Sell
227,094
-512,145
-69% -$935K 0.07% 108
2024
Q2
$1.24M Sell
739,239
-30,000
-4% -$62.5K 0.17% 101
2024
Q1
$1.98M Hold
769,239
0.28% 76
2023
Q4
$1.52M Sell
769,239
-550,000
-42% -$480K 0.25% 80
2023
Q3
$1.23M Buy
1,319,239
+89,431
+7% +$98.4K 0.22% 74
2023
Q2
$1.4M Buy
+1,229,808
New +$1.07M 0.22% 77
2020
Q3
Sell
-200,000
Closed -$3M 101
2020
Q2
$3M Buy
+200,000
New +$2.7M 0.28% 65
2014
Q2
Sell
-69,109
Closed -$726K 101
2014
Q1
$726K Buy
+69,109
New +$761K 0.17% 96

Other funds holding CGEN

Sphera Funds Management's CGEN Position: Q1 2025 in Review

Sphera Funds Management sold out of Compugen (CGEN) in Q1 2025, closing a stake of 177,094 shares — an estimated $271K sold.

Sphera Funds Management first reported a position in CGEN in Q1 2014 and held it in 9 quarters. The position peaked at $3M in Q2 2020. 71 funds tracked by Wall St. Rank hold CGEN as of Q1 2025.

  • Sphera Funds Management reported no remaining Compugen position as of Q1 2025 after selling out during the quarter.
  • Sphera Funds Management sold 177,094 Compugen shares in Q1 2025, an estimated $271K.
  • Sphera Funds Management first reported a position in Compugen in Q1 2014 and held it in 9 quarters.
  • Sphera Funds Management's Compugen position peaked at $3M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Compugen as of Q1 2025.

Based on Sphera Funds Management's 13F filing for Q1 2025, filed 15 May 2025.